135 related articles for article (PubMed ID: 37817739)
1. CLINICAL VIEW ON SUBSTANCE-INDUCED PSYCHOTIC SYMPTOMS IN A MEDICALLY SUPERVISED INJECTING ROOM: A DECADE OF EXPERIENCE.
Palma-Álvarez RF; Daigre C; Ballabriga-Córdoba T; Monterde-Ochoa E; Sierra-Fortuny M; Cantillo M; Pelaez M; Castrillo E; Camañes L; Roncero C; Ramos-Quiroga JA; Grau-López L
Actas Esp Psiquiatr; 2023 Jul; 51(4):188-191. PubMed ID: 37817739
[TBL] [Abstract][Full Text] [Related]
2. Perceptions about supervised injection facilities among people who inject drugs in Philadelphia.
Harris RE; Richardson J; Frasso R; Anderson ED
Int J Drug Policy; 2018 Feb; 52():56-61. PubMed ID: 29241143
[TBL] [Abstract][Full Text] [Related]
3. Adapting harm reduction services during COVID-19: lessons from the supervised injecting facilities in Australia.
Roxburgh A; Jauncey M; Day C; Bartlett M; Cogger S; Dietze P; Nielsen S; Latimer J; Clark N
Harm Reduct J; 2021 Feb; 18(1):20. PubMed ID: 33596940
[TBL] [Abstract][Full Text] [Related]
4. The Melbourne Safe Injecting Room Attracted People Most in Need of Its Service.
Van Den Boom W; Del Mar Quiroga M; Fetene DM; Agius PA; Higgs PG; Maher L; Hickman M; Stoové MA; Dietze PM
Am J Prev Med; 2021 Aug; 61(2):217-224. PubMed ID: 34011443
[TBL] [Abstract][Full Text] [Related]
5. Public injecting and its association with mental health and other drug-related outcomes among people who inject drugs in Iran.
Khezri M; Tavakoli F; Karamouzian M; Sharifi H; Ghalehkhani N; Mousavian G; Mehmandoost S; Bazargani M; Hosseinpour AM; Mahboubi M; Baral S; Shokoohi M
J Subst Abuse Treat; 2022 Dec; 143():108868. PubMed ID: 36137306
[TBL] [Abstract][Full Text] [Related]
6. Voices represented and voices silenced: Represented voices in the media coverage of the implementation of a supervised injecting facility.
Whiteside B; Dunn M
Int J Drug Policy; 2023 Nov; 121():104213. PubMed ID: 37776603
[TBL] [Abstract][Full Text] [Related]
7. Understanding the public health consequences of suspending a rural syringe services program: a qualitative study of the experiences of people who inject drugs.
Allen ST; Grieb SM; O'Rourke A; Yoder R; Planchet E; White RH; Sherman SG
Harm Reduct J; 2019 May; 16(1):33. PubMed ID: 31109339
[TBL] [Abstract][Full Text] [Related]
8. Twenty-one years at the Uniting Medically Supervised Injecting Centre, Sydney: addressing the remaining questions.
Day CA; Salmon A; Jauncey M; Bartlett M; Roxburgh A
Med J Aust; 2022 Oct; 217(8):385-387. PubMed ID: 36259283
[No Abstract] [Full Text] [Related]
9. Using drugs in un/safe spaces: Impact of perceived illegality on an underground supervised injecting facility in the United States.
Davidson PJ; Lopez AM; Kral AH
Int J Drug Policy; 2018 Mar; 53():37-44. PubMed ID: 29278831
[TBL] [Abstract][Full Text] [Related]
10. Mental health among clients of the Sydney Medically Supervised Injecting Centre (MSIC).
Goodhew M; Salmon AM; Marel C; Mills KL; Jauncey M
Harm Reduct J; 2016 Oct; 13(1):29. PubMed ID: 27733167
[TBL] [Abstract][Full Text] [Related]
11. Acceptability of safe drug consumption spaces among people who inject drugs in rural West Virginia.
O'Rourke A; White RH; Park JN; Rodriguez K; Kilkenny ME; Sherman SG; Allen ST
Harm Reduct J; 2019 Aug; 16(1):51. PubMed ID: 31470864
[TBL] [Abstract][Full Text] [Related]
12. The experiences of people who inject drugs of skin and soft tissue infections and harm reduction: A qualitative study.
Dunleavy K; Hope V; Roy K; Taylor A
Int J Drug Policy; 2019 Mar; 65():65-72. PubMed ID: 30665085
[TBL] [Abstract][Full Text] [Related]
13. Supervised injection services: what has been demonstrated? A systematic literature review.
Potier C; Laprévote V; Dubois-Arber F; Cottencin O; Rolland B
Drug Alcohol Depend; 2014 Dec; 145():48-68. PubMed ID: 25456324
[TBL] [Abstract][Full Text] [Related]
14. Supervised Injection Facility Utilization Patterns: A Prospective Cohort Study in Vancouver, Canada.
Kennedy MC; Klassen DC; Dong H; Milloy MS; Hayashi K; Kerr TH
Am J Prev Med; 2019 Sep; 57(3):330-337. PubMed ID: 31377091
[TBL] [Abstract][Full Text] [Related]
15. Supervised Inhalation Sites: Preventing Overdose and Reducing Health Inequities among People Who Use Drugs.
Lu A; Kim C; Rosen JG; Thompson E; Tardif J; Welwean R; Park JN
Subst Use Misuse; 2024; 59(4):520-526. PubMed ID: 38044494
[TBL] [Abstract][Full Text] [Related]
16. Eliminating hepatitis C in Australia: a novel model of hepatitis C testing and treatment for people who inject drugs at a medically supervised injecting facility.
MacIsaac MB; Whitton B; Hubble A; Cogger S; Penn M; Weeks A; Elmore K; Pemberton D; Anderson J; Howard R; McKeever U; Papaluca T; Hellard ME; Stoove M; Wilson D; Pedrana A; Doyle J; Clark N; Holmes J; Thompson AJ
Med J Aust; 2023 Apr; 218(6):256-261. PubMed ID: 36919230
[TBL] [Abstract][Full Text] [Related]
17. Ireland is to install supervised injecting rooms.
Houston M
BMJ; 2016 Jan; 532():i406. PubMed ID: 26801053
[No Abstract] [Full Text] [Related]
18. Supervised injection facility use and all-cause mortality among people who inject drugs in Vancouver, Canada: A cohort study.
Kennedy MC; Hayashi K; Milloy MJ; Wood E; Kerr T
PLoS Med; 2019 Nov; 16(11):e1002964. PubMed ID: 31770391
[TBL] [Abstract][Full Text] [Related]
19. The print media's construction of the 'drug problem' in Victorian newspapers: The case of North Richmond Community Health's medically supervised injecting room.
Whiteside B; Dunn M
Drug Alcohol Rev; 2022 May; 41(4):818-829. PubMed ID: 34674323
[TBL] [Abstract][Full Text] [Related]
20. Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study.
Marshall BD; Milloy MJ; Wood E; Montaner JS; Kerr T
Lancet; 2011 Apr; 377(9775):1429-37. PubMed ID: 21497898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
